CBT
AVNS icon

CoreFirst Bank & Trust’s Avanos Medical AVNS Stock Holding History

CoreFirst Bank & Trust’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-78
Closed -$3K – 444
2021
Q2 		$3K Hold
78
– – ﹤0.01% 431
2021
Q1 		$3K Hold
78
– – ﹤0.01% 429
2020
Q4 		$4K Buy
+78
New +$3.25K ﹤0.01% 398

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CoreFirst Bank & Trust's AVNS Position: Q3 2021 in Review

CoreFirst Bank & Trust sold out of Avanos Medical (AVNS) in Q3 2021, closing a stake of 78 shares — an estimated $3K sold.

CoreFirst Bank & Trust first reported a position in AVNS in Q4 2020 and held it in 3 quarters. The position peaked at $4K in Q4 2020. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2021.

  • CoreFirst Bank & Trust reported no remaining Avanos Medical position as of Q3 2021 after selling out during the quarter.
  • CoreFirst Bank & Trust sold 78 Avanos Medical shares in Q3 2021, an estimated $3K.
  • CoreFirst Bank & Trust first reported a position in Avanos Medical in Q4 2020 and held it in 3 quarters.
  • CoreFirst Bank & Trust's Avanos Medical position peaked at $4K in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2021.

Based on CoreFirst Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.